参考文献/References:
[1] CAO Y,YANG Y,HU Q,et al.Identification of potential drug targets for rheumatoid arthritis from genetic insights:a mendelian randomization study[J].J Transl Med,2023,21(1):616-628.
[2] KIM Y,YANG H I,KIM K S.Etiology and pathogenesis of rheumatoid arthritis-interstitial lung disease[J].Int J Mol Sci,2023,24(19):14509-14521.
[3] DWIVEDI S D,YADAV K,BHOI A,et al.Targeting pathways and integrated approaches to treat rheumatoid arthritis[J].Crit Rev Ther Drug Carrier Syst,2024,41(4):87-102.
[4] ZHANG M,QIANG Y.Catalpol ameliorates inflammation and oxidative stress via regulating Sirt1 and activating Nrf2/HO-1 signaling against acute kidney injury[J].Environ Toxicol,2023,38(9):2182-2191.
[5] CAI C,SUN P,CHEN Z,et al.Catalpol protects mouse ATDC5 chondrocytes against interleukin-1β-induced catabolism[J].Histol Histopathol,2024,39(3):333-344.
[6] DI Y,ZHANG M,CHEN Y,et al.Catalpol inhibits tregs-to-Th17 cell transdifferentiation by up-regulating let-7g-5p to reduce STAT3 protein levels[J].Yonsei Med J,2022,63(1):56-65.
[7] 李光淳,李高峰,张兆琦,等.枸杞多糖对类风湿关节炎大鼠炎症反应及TLR4/NF-κB信号通路的影响[J].中国老年学杂志,2024,44(5):1119-1124.
[8] 马蒂达,吴洋,王显,等.桃叶珊瑚苷通过AMPK/NLRP3通路对心肌梗死大鼠心功能的影响及机制[J].贵州医科大学学报,2021,46(7):773-780.
[9] YAMADA S,NAGAFUCHI Y,FUJIO K.Pathophysiology and stratification of treatment-resistant rheumatoid arthritis[J].Immunol Med,2024,47(1):12-23.
[10] SALEHI S,MAHMOUDINEZHAD DEZFOULI S M,AZADEH H,et al.Immune dysregulation and pathogenic pathways mediated by common infections in rheumatoid arthritis[J].Folia Microbiol(Praha),2023,68(3):325-335.
[11] ZENG Y F,WANG R,BIAN Y,et al.Catalpol attenuates IL-1β induced matrix catabolism,apoptosis and inflammation in rat chondrocytes and inhibits cartilage degeneration[J].Med Sci Monit,2019,25(3):6649-6659.
[12] MENG J,ZHANG W,WANG C,et al.Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity[J].Biochem Pharmacol,2020,171(3):113715-113726.
[13] JIA Y,FENG B,JI X,et al.Complement factor H attenuates TNF-α-induced inflammation by upregulating EIF3C in rheumatoid arthritis[J].J Transl Med,2023,21(1):846-857.
[14] 王永涛,谢一舟,樊效鸿,等.加味当归四逆汤对膝骨关节炎大鼠软骨退变的影响及作用机制研究[J].中国中医骨伤科杂志,2022,30(11):7-12.
[15] MA C,WANG X,XU T,et al.Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 inflammasome signalling pathway[J].BMC Complement Altern Med,2019,19(1):320-321.
[16] GUO C,FU R,WANG S,et al.NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis[J].Clin Exp Immunol,2018,194(2):231-243.
[17] CHEN P K,TANG K T,CHEN D Y.The NLRP3 inflammasome as a pathogenic player showing therapeutic potential in rheumatoid arthritis and its comorbidities:a narrative review[J].Int J Mol Sci,2024,25(1):626-638.